Hydrozid is a portable aerosol cryosurgical device for the treatment of benign and precancerous skin lesions. It uses the medically approved gas norflurane as a cryogen, which is non-toxic, non-flammable and does not harm the ozone layer.
Key features:
Safety: Hydrozide can be used without protective equipment and does not require special storage conditions;
Effectiveness:provides fast and effective treatment of a wide range of skin lesions such as warts, seborrhoeic keratosis, actinic keratosis, skin tags, etc;
easy to use:ready to use without additional preparation, easily controlled by direct spraying on the lesion;
Cost-effective: itdoes not require a large initial investment, has a long shelf-life of 3 years and can be disposed of as normal waste.
Hydrozide is approved for use in Europe and the USA for professional use in the treatment of a wide range of skin conditions.
